⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8880520 | 0.75 | — | — | |
| SCHEMBL8699047 | 0.75 | — | — | |
| SCHEMBL5598731 | 0.75 | CRBN (0.43) | — | |
| SCHEMBL8692835 | 0.73 | CRBN (0.41) | — | |
| SCHEMBL10531811 | 0.73 | CRBN (0.41) | — | |
| SCHEMBL11583227 | 0.72 | TOP2A (0.42) | — | |
| SCHEMBL9849517 | 0.70 | CRBN (0.38) | — | |
| SCHEMBL11580584 | 0.69 | CRBN (0.38) | — | |
| SCHEMBL11580736 | 0.68 | CRBN (0.36) | — | |
| SCHEMBL1980040 | 0.68 | CRBN (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022197927-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DRUG RESISTANT TOPICAL INFECTIONS | LANKENAU INSTITUTE FOR MEDICAL RESEARCH (US) | 2022-09-22 | — | — | WO | claimed |
| WO-2022197927-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF DRUG RESISTANT TOPICAL INFECTIONS | LANKENAU INSTITUTE FOR MEDICAL RESEARCH (US) | 2022-09-22 | — | — | WO | disclosed |
| US-11433136-B2 | Polyacetal polymers, conjugates, particles and uses thereof | THE GENERAL HOSPITAL CORPORATION (US) | 2022-09-06 | — | — | US | disclosed |
| WO-2018106738-A1 | BRUSH-ARM STAR POLYMERS, CONJUGATES AND PARTICLES, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-06-14 | — | — | WO | disclosed |
| WO-2018098206-A1 | HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS | CV6 THERAPEUTICS (NI) LIMITED (GB) | 2018-05-31 | — | — | WO | disclosed |
| EP-0427942-A2 | Process for the preparation of s-triazine-sulfenimides and their use | Degussa Aktiengesellschaft (DE) | 1991-05-22 | — | — | EP | disclosed |
| EP-0098456-B1 | PEPTIDES COMPRISING A (1S,2R,3R)- OR (1R,2S,3S)-1-NITRILO-1-CARBONYL-3-METHYL-2-OXY-HEPTANE OR -HEPT-5-ENE RESIDUE USEFUL IN THE TOTAL SYNTHESIS OF CYCLOSPORINS, AND PROCESSES FOR THEIR PRODUCTION | SANDOZ AG (CH) | 1989-05-24 | — | — | EP | disclosed |
| EP-0098457-B1 | (1S,2R,3R)- AND (1R,2S,3S)-NITRILO-1-CARBONYL-3-METHYL-2-OXY-HEPTANES AND -HEPT-5-ENES USEFUL IN THE TOTAL SYNTHESIS OF CYCLOSPORINS AND PROCESSES FOR THEIR PRODUCTION | SANDOZ AG (CH) | 1987-08-05 | — | — | EP | disclosed |
| US-4088751-A | SHAVING CREAM, SHAMPOO, LOTION, 2-THIO-4-OXYPYRIMIDINE OR THIOHYDANTOIN AND HYDROGEN PEROXIDE, EXOTHERMIC REDOX REACTION | COLGATE-PALMOLIVE COMPANY (US) | 1978-05-09 | — | — | US | disclosed |